A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,868,335 shares of BLFS stock, worth $61.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,868,335
Previous 2,571,608 11.54%
Holding current value
$61.3 Million
Previous $41.8 Million 27.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$15.35 - $18.82 $4.55 Million - $5.58 Million
296,727 Added 11.54%
2,868,335 $53.2 Million
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $276,559 - $518,664
30,763 Added 1.21%
2,571,608 $41.8 Million
Q3 2023

Nov 14, 2023

SELL
$10.81 - $22.96 $228,826 - $486,017
-21,168 Reduced 0.83%
2,540,845 $35.1 Million
Q2 2023

Aug 14, 2023

BUY
$17.19 - $24.34 $1.23 Million - $1.74 Million
71,667 Added 2.88%
2,562,013 $56.6 Million
Q1 2023

May 15, 2023

BUY
$17.67 - $26.07 $413,743 - $610,429
23,415 Added 0.95%
2,490,346 $54.2 Million
Q4 2022

Feb 10, 2023

BUY
$16.95 - $25.07 $871,569 - $1.29 Million
51,420 Added 2.13%
2,466,931 $44.9 Million
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $4.57 Million - $8.33 Million
311,913 Added 14.83%
2,415,511 $55 Million
Q2 2022

Aug 12, 2022

SELL
$10.54 - $24.2 $1.03 Million - $2.37 Million
-98,004 Reduced 4.45%
2,103,598 $29.1 Million
Q1 2022

May 13, 2022

BUY
$20.81 - $37.29 $1.13 Million - $2.03 Million
54,344 Added 2.53%
2,201,602 $50 Million
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $2.06 Million - $3.66 Million
62,456 Added 3.0%
2,147,258 $80 Million
Q3 2021

Nov 12, 2021

BUY
$42.03 - $60.5 $14.1 Million - $20.2 Million
334,308 Added 19.1%
2,084,802 $88.2 Million
Q2 2021

Aug 13, 2021

BUY
$29.51 - $44.62 $51.7 Million - $78.1 Million
1,750,494 New
1,750,494 $77.9 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $912M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.